As of 2024-12-15, the EV/EBITDA ratio of bluebird bio Inc (BLUE) is -6.62. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLUE's latest enterprise value is 1,334.55 mil USD. BLUE's TTM EBITDA according to its financial statements is -201.57 mil USD. Dividing these 2 quantities gives us the above BLUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.4x - 15.1x | 13.8x |
| Forward P/E multiples | 13.4x - 15.3x | 15.0x |
| Fair Price | (14.39) - (16.14) | (15.45) |
| Upside | -327.0% - -354.5% | -343.7% |
| Date | EV/EBITDA |
| 2024-12-13 | -6.62 |
| 2024-12-12 | -7.84 |
| 2024-12-11 | -8.06 |
| 2024-12-10 | -8.57 |
| 2024-12-09 | -9.17 |
| 2024-12-06 | -9.29 |
| 2024-12-05 | -9.07 |
| 2024-12-04 | -14.71 |
| 2024-12-03 | -7.42 |
| 2024-12-02 | -8.55 |
| 2024-11-29 | -8.32 |
| 2024-11-27 | -7.79 |
| 2024-11-26 | -7.64 |
| 2024-11-25 | -7.48 |
| 2024-11-22 | -7.26 |
| 2024-11-21 | -6.25 |
| 2024-11-20 | -6.35 |
| 2024-11-19 | -6.39 |
| 2024-11-18 | -6.93 |
| 2024-11-15 | -6.69 |
| 2024-11-14 | -7.50 |
| 2024-11-13 | -7.76 |
| 2024-11-12 | -8.04 |
| 2024-11-11 | -8.32 |
| 2024-11-08 | -8.33 |
| 2024-11-07 | -7.88 |
| 2024-11-06 | -8.98 |
| 2024-11-05 | -9.23 |
| 2024-11-04 | -9.44 |
| 2024-11-01 | -9.50 |
| 2024-10-31 | -9.46 |
| 2024-10-30 | -9.94 |
| 2024-10-29 | -9.99 |
| 2024-10-28 | -10.05 |
| 2024-10-25 | -9.77 |
| 2024-10-24 | -10.13 |
| 2024-10-23 | -10.40 |
| 2024-10-22 | -10.26 |
| 2024-10-21 | -10.09 |
| 2024-10-18 | -9.97 |
| 2024-10-17 | -9.89 |
| 2024-10-16 | -9.80 |
| 2024-10-15 | -9.79 |
| 2024-10-14 | -10.21 |
| 2024-10-11 | -10.27 |
| 2024-10-10 | -10.05 |
| 2024-10-09 | -10.05 |
| 2024-10-08 | -9.90 |
| 2024-10-07 | -10.55 |
| 2024-10-04 | -11.50 |